Women Living with HIV
Cross-source consensus on Women Living with HIV from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Risks & contraindications
Background
Highlighted claims
- WLHIV carry approximately 2.6 times the relative risk of acquiring HPV compared to HIV-negative women and demonstrate a lower rate of HPV clearance. — Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol
- WLHIV face a sixfold increased risk of developing cervical cancer compared to the general population. — Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol
- As of 2023, an estimated 2.5 million people were living with HIV in India, making it the third-highest country globally in absolute numbers. — Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol
- Women with higher CD4 counts experience slower cervical disease progression than those with lower CD4 counts, reflecting the role of immune status. — Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol
- ART has improved life expectancy for WLHIV, but this extended lifetime inadvertently prolongs HPV exposure and increases the probability of progression to invasive cervical cancer. — Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol
- In practice, WLHIV are typically referred for cervical evaluation only when they present with symptomatic disease, rather than at routine screening intervals. — Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol